On July 9th, Demao Chen, who is the director of nephrology department of Queen Mary Hospital and the specially-appointed professor of Hong Kong University, visited our hospital. He was invited by Zhaohui Ni the director of our Nephrology to visit our Hospital for cooperation with the nephrology and rheumatology carried on depth exchanges. Professor Zhaohui Ni, director of nephrology chaired the meeting.
Professor Demao Chen is the director of nephrology department of Queen Mary Hospital, the specially-appointed professor of University of Hong Kong, and also an internationally renowned expert on nephrology. He has obtained a world-class research especially in terms of lupus nephritis. In 2000, Professor Chen first proposed in the New England Journal of Medicine's international mycophenolate mofetil (MMF) in severe effect on the treatment of lupus nephritis, and led the team study deeply of the mechanism and function of anti-ds-DNA with cells in renal damage. Research was published in JASN, Kidney International, Nature Review Nephrology, J Autoimmununity, Rheumatology and other famous international magazines. Professor Shunle Chen was also invited to attend the meeting and participate in the discussion. Professor Chen has made outstanding contribution for Chinese scholars rheumatism, especially experimental and clinical studies of systemic lupus erythematosus.
There are many exchanges and cooperation between Hong Kong University School of Medicine, Queen Mary Hospital and Renji Hospital Nephrology Nephrology in research, clinical field. Professor Demao Chen reached a cooperation intention about nephrology, rheumatology research lupus nephritis direction with our hospital. We will jointly carry out an international multi-center, prospective, randomized controlled clinical trials. The treatment programs in developing clinical trials will be conducive to study lupus nephritis Asian populations hormone treatment and a pioneering research for the Asian population of lupus nephritis. This will greatly promote the development of treatment of lupus nephritis in China.
(Reporter Xinghua Shao; Translator Jing Gu)